Cell Culture Vessels Market
Cell Culture Vessels Market by Product [Vessels (Roller Bottles, Flasks, Cell Factory, Multiwell Plates), Accessories], Application [mAbs, Vaccines, CGT], End User [Pharma Biotech, Academia], Region - Global Forecast to 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The cell culture vessels market is projected to reach USD 8.03 billion by 2030 from USD 5.10 billion in 2025, at a CAGR of 9.5% from 2025 to 2030. Growth in the global cell culture vessels market is tied to the expansion of biopharma manufacturing worldwide. Demand is rising for biologics such as monoclonal antibodies, vaccines, and recombinant proteins. This is driving high, repeated use of flasks, plates, spinner flasks, roller bottles, and single-use bags across upstream workflows. Cell and gene therapy is another strong driver. These programs prefer closed, single-use vessels to reduce contamination risk and simplify changeovers. CDMOs are also adding capacity in the US, Europe, and Asia, increasing bulk purchases and standardizing vessel formats. At the same time, more labs are moving to automated, high-throughput culture, which favors consistent, sensor-ready, and robotics-compatible vessels.
KEY TAKEAWAYS
-
By RegionThe North America cell culture vessels market accounted for a 39.6% revenue share in 2024.
-
By ProductBy product, the cell culture vessels market cell factory systems/cell stacks (vessel type) segment is expected to dominate the market in 2024.
-
By ApplicationBy application, the biopharmaceutical production segment is projected to grow at the fastest rate from 2025 to 2030.
-
By End userBy end user, the pharmaceutical & biotechnology companies segment is projected to grow at the fastest rate from 2025 to 2030.
-
Competitive LandscapeCompanies such as Thermo Fisher Scientific, Merck KGaA, and Corning Incorporeated were identified as some of the key players in the cell culture vessels market, given their strong market share and product footprint.
-
Competitive LandscapeCompanies such as Cellexus and Solida Biotech GmbH, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders
The global cell culture vessels market is expanding steadily as more labs and manufacturers rely on scalable, repeatable cell growth systems. Demand is rising for better in vitro models and higher productivity in upstream processing, which is increasing consumption of plates, flasks, roller bottles, and single-use bags. Growth in biologics manufacturing, especially in monoclonal antibodies and vaccines, is driving high vessel adoption across seed train and scale-up steps.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The impact on stakeholders’ businesses in the global cell culture vessels market is shaped by the rapid shift toward biologics, advanced therapies, and personalized medicine, which is driving sustained demand for flasks, multiwell plates, roller bottles, bags, and bioreactor vessels used in upstream processing and cell-based research. Expansion of development and manufacturing programs by biopharma companies and CDMOs is supporting high utilization of both reusable and, predominantly, single-use vessels. This is mainly because these formats support flexible, contamination-controlled workflows for monoclonal antibodies, biosimilars, vaccines, and cell and gene therapies.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Growing biomanufacturing of vaccines and biologics
-
Rapid growth of closed and single-use workflows in CGT manufacturing
Level
-
Supply constraints and longer lead times for single-use components
Level
-
Developing standardized and multi-sourced vessel designs
Level
-
Extractables and leachables expectations for plastic vessel contact materials
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing biomanufacturing of vaccines and biologics
Global biologics and vaccine output is rising steadily. This is directly driving demand for culture vessels used in seed trains and scale-up. Single-use bags and closed vessel assemblies are preferred in many multiproduct plants. They reduce cleaning time and minimize carryover risk between batches. This matters even more for viral vectors and gene-based medicines. CDMOs also prefer single-use because it enables faster changeovers across clients. These factors are supporting high vessel volumes and short refresh cycles.
Restraint: Supply constraints and longer lead times for single-use components
Single-use demand has grown faster than supply capacity in some areas. Lead times for key materials and assemblies can lengthen. Custom designs complicate sourcing and slow substitutions. Supply constraints have increased lead times for single-use raw materials. The lack of standardization also adds complexity for biomanufacturers, which can delay production planning and vessel procurement and promote buyer preference for long-term supply contracts.
Opportunity: Developing standardized and multi-sourced vessel designs
Standardization is becoming a practical buying strategy. It reduces the number of specialized, unique bags and vessel variants in a plant. It also makes dual-sourcing more realistic. Market players have positioned standardization as a path to supply resilience. Vendors that offer interoperable and consistent designs can earn preferred supplier status. This is an opportunity in CDMOs and large biopharma networks. It also supports faster technology transfer across sites.
Challenge: Extractables and leachables expectations for plastic vessel contact materials
Plastic contact surfaces can release extractables that become leachables in process fluids. This can affect quality, stability, and, in some cases, safety. Industry attention is rising due to USP work on plastic components in manufacturing. USP lists <665> as a key upcoming chapter for manufacturing components. Related guidance increases qualification workload. This is a real challenge for both suppliers and end users. It is also making change control more sensitive.
CELL CULTURE VESSELS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Sartorius enabled a fully closed single-use approach for a multi-product mammalian cell culture platform. The objective was a fast start-up facility under cGMP expectations (US/EU/China). The case emphasizes plug-and-play scale and disposable equipment from 50 L to 2,000 L | Faster facility start-up | Closed processing mindset | Scalable from development to GMP | Better fit for changing client demand |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The cell culture vessels market ecosystem spans material suppliers, vessel manufacturers, and end users in research and biomanufacturing. On the supply side, polymer and film suppliers, resin formulators, and sterile packaging partners enable the consistent production of flasks, plates, roller bottles, and single-use bags. Life-science suppliers and vessel manufacturers then convert these components into both standard and niche formats, such as tissue-culture-treated surfaces, low-attachment vessels, and closed single-use assemblies with ports and connectors. End users include biopharma companies and CDMOs that operate seed-train and scale-up processes, as well as academic institutes, hospitals, and clinical labs that use vessels for routine culture and cell-based assays.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Cell culture vessels market, By Product
The cell culture vessels market for products is divided into vessels and accessories. In 2024, cell factory systems/cell stacks dominated the vessels segment of the cell culture market. This dominance is driven by their practicality for scaling adherent cell culture without moving to complex stirred systems. Biopharma and CDMOs use cell stacks heavily for seed expansion and for processes that still rely on adherent growth. They also fit well in GMP settings due to closed-handling options and repeatable performance. Demand is supported by vaccine and viral vector workflows, where adherent or semi-adherent steps are common.
Cell culture vessels market, By Type
In 2024, single-use cell culture vessels dominated the market. This dominance is driven by biopharma and CDMOs' preference for pre-sterilized, ready-to-use formats that reduce operational friction. Single-use vessels help limit cross-contamination risk and eliminate cleaning and sterilization steps, cutting turnaround time between batches. Single-use bags and closed assemblies also fit well with cell and gene therapy workflows, where open handling poses a significant risk.
Cell culture vessels market, By Application
As of 2024, biopharmaceutical production was the dominant application in the global cell culture vessels market. This dominance stems from the need for a steady supply of culture vessels across seed train, scale-up, and routine process development in large-scale biologics manufacturing. Facilities consume high volumes of flasks, multi-layer cell stacks, and single-use vessels to keep production timelines on track. Demand is also sustained by ongoing production of monoclonal antibodies, vaccines, and recombinant proteins, where upstream cell growth is the starting point for every batch.
Cell culture vessels market, By End user
As of 2024, pharmaceutical and biotechnology companies accounted for the largest share of the global cell culture vessels market. This is largely because they conduct the highest volume of cell culture work across discovery, process development, and commercial production. Their labs and manufacturing sites consume large quantities of flasks, plates, and multi-layer cell stacks on a recurring basis. They also invest heavily in single-use and closed-vessel formats to reduce contamination risk and speed up changeovers. This combination of scale, repeat use, and quality-driven procurement makes pharma and biotech companies the most dominant end-user group in the market.
REGION
Asia Pacific to be the fastest-growing region in the cell culture vessels market during the forecast period
The Asia Pacific is the fastest-growing region, as countries such as China, India, South Korea, Japan, and Singapore continue to expand biomanufacturing capacity and strengthen local supply chains. The increasing number of CDMO build-outs and biosimilar scale-up programs is driving the routine use of plates, flasks, and high-surface-area systems, such as cell stacks. The region is also adopting single-use and closed culture vessels faster to reduce contamination risk and speed up changeovers in multi-product facilities.
CELL CULTURE VESSELS MARKET: COMPANY EVALUATION MATRIX
Thermo Fisher Scientific (Star) is a leading player in the global cell culture vessels market, driven by its broad, high-velocity portfolio of everyday cultureware used across research labs, biopharma manufacturers, and CDMOs. Through brands such as Nunc, the company offers a wide range of cell culture flasks, multiwell plates, dishes, and specialized treated surfaces that are repeatedly purchased for routine culture, scale-up support, and cell-based assays. Eppendorf (Emerging Leader) is strengthening its position in the cell culture vessels market by expanding adoption in both research and process development environments, where users value workflow fit and ease of handling.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific, Inc. (US)
- Danaher Corporation (US)
- Sartorius AG (Germany)
- Corning Incorporated (US)
- Eppendorf SE (Germany)
- BD (US)
- Lonza (Switzerland)
- Getinge (Sweden)
- Solida Biotech GmbH (Germany)
- Meissner Filtration Products (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 4.09 Billion |
| Market Forecast in 2030 (Value) | USD 6.67 Billion |
| Growth Rate | CAGR of 9.2% from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
WHAT IS IN IT FOR YOU: CELL CULTURE VESSELS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| US-based cell & gene therapy company |
|
|
| Chemical Corporation | Strategic analysis of product type and application subsegments based on the scale of operations – R&D and commercial scale operations (including scale-up) |
|
RECENT DEVELOPMENTS
- September 2024 : Merck KGaA (Germany) launched the first single-use reactor specifically designed for the manufacture of antibody drug conjugates (ADCs).
- July 2024 : Merck invested around USD 7.1 million (EUR 6.6 million) for the expansion of commercial production of its first GMP-compliant manufacturing line for cell culture in China.
- December 2022 : Shenandoah Biotechnology Inc., a FUJIFILM Irvine Scientific (Japan) company, expanded its CTGrade portfolio of cytokines and growth factors for cell and gene therapies manufactured following cGMP guidelines.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Cell Culture Vessels Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Cell Culture Vessels Market